Blood Collection Market
By Collection Site;
Venous [Needles & Syringes (Double-Ended Needles, Winged Blood Collection Sets, Standard Hypodermic Needles and Others), Blood Collection Tubes (Serum-Separating, EDTA, Heparin and Plasma-Separating), Blood Bags and Others] and Capillary [Lancets, Micro-Container Tubes, Micro-Hematocrit Tubes, Warming Devices and Others]By Application;
Diagnostics and TreatmentBy Collection Method;
Manual Blood Collection and Automated Blood CollectionBy End Use;
Hospitals, Diagnostics Centers, Blood Banks, Emergency Departments and OthersBy Geography;
North America, Europe, Asia Pacific, Middle East & Africa and Latin America - Report Timeline (2021 - 2031)Blood Collection Market Overview
Blood Collection Market (USD Million)
Blood Collection Market was valued at USD 7,687.09 million in the year 2024. The size of this market is expected to increase to USD 11,635.09 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 6.1%.
Blood Collection Market
*Market size in USD million
CAGR 6.1 %
| Study Period | 2025 - 2031 | 
|---|---|
| Base Year | 2024 | 
| CAGR (%) | 6.1 % | 
| Market Size (2024) | USD 7,687.09 Million | 
| Market Size (2031) | USD 11,635.09 Million | 
| Market Concentration | Medium | 
| Report Pages | 379 | 
Major Players
- Abbott Laboratories
- Becton, Dickinson and Company (BD)
- Terumo Corporation
- F. Hoffmann-La Roche Ltd.
- Grifols, S.A.
- Haemonetics Corporation
- Immucor, Inc.
- Bio-Rad Laboratories, Inc.
- Ortho Clinical Diagnostics
- Fresenius Kabi AG
Market Concentration
Consolidated - Market dominated by 1 - 5 major players
Blood Collection Market
Fragmented - Highly competitive market without dominant players
The Blood Collection Market is expanding rapidly due to its vital role in diagnostics and treatment. Nearly 60% of medical interventions depend on blood testing or transfusion, reflecting its importance in healthcare. More than 55% of patients undergo routine blood tests, making this industry a cornerstone of modern medical practices.
Innovations Driving Safer Practices
The adoption of advanced blood collection devices has improved efficiency and safety. Automated systems now account for almost 40% of all collections, reducing errors and contamination. Over 45% of laboratories are shifting to closed-system devices, ensuring sterility and enhancing patient as well as operator safety.
Expanding Need for Transfusions and Testing
The rising demand for blood transfusions and diagnostic screening strengthens market growth. More than 50% of emergency medical procedures require immediate blood supplies, while close to 35% of disease diagnoses rely on blood analysis. This dependency highlights the significance of robust collection systems in healthcare delivery.
Digital Integration and Automation
The market is embracing digital and automated solutions to improve efficiency. Around 50% of healthcare providers use automated monitoring for traceability and error reduction. Meanwhile, over 45% of blood banks rely on digital tracking systems, showcasing the sector’s steady move toward smart and efficient practices.
Blood Collection Market Key Takeaways
-  Diagnostics drive the majority of collections—rising prevalence of chronic diseases, infections, and preventive testing continues to underpin steady demand for blood collection procedures. 
-  Conventional venous collection remains dominant—needles, syringes, and blood bags continue to account for a significant share due to established clinical practices and cost efficiency. 
-  Automation and closed-system technologies gaining traction—automated collection systems help reduce contamination risk and improve efficiency in large-scale hospital and blood bank operations. 
-  Asia-Pacific exhibits fastest growth momentum—expanding diagnostics infrastructure, rising healthcare awareness, and government-led blood donation campaigns are accelerating regional adoption. 
-  Increasing surgical volumes boost product demand—growing frequency of surgeries, trauma cases, and transplants directly supports higher utilization of blood collection consumables. 
-  Consumables remain the highest revenue contributor—frequent replacement of tubes, bags, and needles sustains strong recurring sales and supply consistency. 
-  Operational and supply challenges persist—donor shortages, regulatory variation, and logistical barriers in maintaining cold chain integrity continue to hinder efficiency in certain markets. 
Blood Collection Market Recent Developments
-  The integration of advanced automation technologies, including robotic phlebotomy systems, is transforming blood collection by improving efficiency and minimizing human errors. This innovation enhances accuracy, streamlines workflows and supports safer, more reliable healthcare delivery. 
-  The adoption of innovative blood collection devices equipped with needlestick prevention and other advanced safety features is enhancing healthcare worker safety. These solutions reduce occupational hazards, promote safer clinical environments and support improved patient care standards. 
Blood Collection Market Segment Analysis
In this report, the Blood Collection Market has been segmented by Collection Site, Application, Collection Method, End Use and Geography.
Blood Collection Market, Segmentation by Collection Site
The Blood Collection Market is categorized by collection site into Venous and Capillary segments, reflecting varied procedural preferences in hospitals and diagnostics centers. Growing healthcare infrastructure and demand for safe blood handling are driving adoption across both segments. The introduction of automated and sterile devices continues to enhance efficiency and reduce contamination risks.
Venous
The Venous blood collection segment holds a major share due to its extensive use in clinical diagnostics and transfusions. Advancements in vacuum-based systems and needle safety technologies have improved procedural efficiency. Increasing hospital admissions and focus on infection prevention further boost this segment’s expansion.
-  Needles & Syringes This sub-segment includes Double-Ended Needles, Winged Blood Collection Sets, Standard Hypodermic Needles and others. Rising demand for single-use safety syringes has led to rapid adoption across hospitals, enhancing patient safety and minimizing cross-contamination. 
-  Blood Collection Tubes Comprising Serum-Separating, EDTA, Heparin and Plasma-Separating tubes, this sub-segment supports diagnostic accuracy. Innovations in additive formulations and barcoded labeling are streamlining laboratory processes and ensuring sample traceability. 
-  Blood Bags Widely used in blood banks, blood bags facilitate efficient collection, storage and transfer. Integration of anticoagulant coatings and improved polymer materials enhances preservation, supporting large-scale transfusion programs and emergency preparedness. 
-  Others This category includes emerging venous collection devices offering better ergonomics and automated withdrawal systems. Focus on user safety and needle-stick injury prevention continues to shape innovation in this space. 
Capillary
The Capillary collection segment caters to point-of-care and pediatric applications where minimal blood volume is required. Portable devices and micro-volume technology are expanding its reach. Growth in home-based diagnostics is further fueling this category’s prominence.
-  Lancets Advanced safety lancets with depth control features dominate this sub-segment, supporting consistent sample quality. The increasing adoption of self-testing kits and digital health devices boosts market expansion. 
-  Micro-Container Tubes These compact tubes enable efficient handling of small-volume samples for laboratory and POC diagnostics. Their role in capillary sampling automation is rising alongside innovation in microfluidic systems. 
-  Micro-Hematocrit Tubes Primarily used for hematocrit analysis, these tubes ensure high accuracy in low-volume testing. Hospitals and research labs prefer these due to their compatibility with advanced centrifugation systems. 
-  Warming Devices Designed to improve blood flow before puncture, warming devices enhance patient comfort and sampling consistency. Increasing application in neonatal care contributes to steady market growth. 
-  Others This segment includes accessories aiding capillary blood collection such as micro-needles and collection strips. Innovation in patient-friendly designs supports its long-term market relevance. 
Blood Collection Market, Segmentation by Application
The Blood Collection Market by application is divided into Diagnostics and Treatment. Increasing chronic disease prevalence and the need for accurate testing drive the diagnostic share, while transfusion medicine and therapeutic procedures underpin treatment demand. Strategic partnerships with diagnostic labs and biotech firms enhance innovation in both categories.
Diagnostics
The diagnostics segment dominates, supported by advancements in automated analyzers and biomarker-based testing. Over 70% of blood samples collected worldwide are used for diagnostic purposes, underscoring its crucial role in disease detection and preventive healthcare.
Treatment
The treatment segment focuses on transfusions, plasma therapy and stem cell harvesting. Increasing incidences of trauma cases and surgical procedures contribute to steady growth. Investments in blood management systems and improved storage practices are enhancing outcomes.
Blood Collection Market, Segmentation by Collection Method
Based on the method, the market is classified into Manual Blood Collection and Automated Blood Collection. The transition toward automation is accelerating due to improved precision, speed and sample integrity. Manufacturers are focusing on technological advancements to meet increasing donor safety standards.
Manual Blood Collection
Manual collection remains prevalent in low-resource settings owing to cost-effectiveness and simplicity. However, the segment faces challenges with operator dependency and human error, prompting gradual adoption of automated alternatives.
Automated Blood Collection
Automation has transformed collection efficiency, especially in large-scale donation centers. Integration of digital monitoring and closed-loop systems enhances sample consistency. Strategic collaborations between medtech firms are boosting global deployment rates.
Blood Collection Market, Segmentation by End Use
The market by end use includes Hospitals, Diagnostics Centers, Blood Banks, Emergency Departments and Others. Expanding healthcare infrastructure and the surge in preventive diagnostics are driving multi-segment growth. Each end user category contributes uniquely to the demand for blood collection systems.
Hospitals
Hospitals form the largest end-use segment, accounting for over half of total demand. Increasing surgical volumes and emergency care cases necessitate reliable blood collection systems, driving procurement of advanced devices.
Diagnostics Centers
Diagnostic centers are witnessing strong adoption of automated collection systems and barcoded tubes for better sample traceability. The rise in preventive testing and chronic disease monitoring supports ongoing expansion.
Blood Banks
Blood banks are central to donation and storage operations, supported by government-funded programs. Innovations in cold chain logistics and bag sterilization continue to improve operational efficiency.
Emergency Departments
Emergency departments depend on rapid and safe collection for trauma and acute care. Growing focus on point-of-care readiness and quick transfusion capability fuels investment in portable collection kits.
Others
This category includes research laboratories and mobile collection units. The integration of AI-enabled traceability and smart tracking systems is redefining operational standards in this segment.
Blood Collection Market, Segmentation by Geography
In this report, the Blood Collection Market has been segmented by Geography into five regions: North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Regions and Countries Analyzed in this Report
North America
North America leads the Blood Collection Market with high adoption of automated systems and stringent safety protocols. The U.S. drives growth through advanced healthcare infrastructure and regulatory compliance supporting innovation in collection devices.
Europe
Europe demonstrates strong growth driven by technological integration in diagnostics and hospital networks. Strategic partnerships among leading manufacturers enhance product standardization and cross-border healthcare efficiency.
Asia Pacific
Asia Pacific shows robust expansion fueled by rising population health initiatives and increasing investments in healthcare infrastructure. Countries such as China and India are witnessing rapid adoption of automated and sterile blood collection technologies.
Middle East & Africa
The Middle East & Africa region is progressing through public health reforms and improved blood bank systems. Government efforts to promote self-sufficiency in blood supplies are creating long-term opportunities for manufacturers.
Latin America
Latin America experiences steady growth due to modernization of hospital facilities and awareness campaigns for voluntary blood donation. Partnerships between local suppliers and international healthcare providers continue to strengthen market presence.
Blood Collection Market Forces
This report provides an in depth analysis of various factors that impact the dynamics of Blood Collection Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Comprehensive Market Impact Matrix
This matrix outlines how core market forces Drivers, Restraints and Opportunities affect key business dimensions including Growth, Competition, Customer Behavior, Regulation and Innovation.
| Market Forces ↓ / Impact Areas → | Market Growth Rate | Competitive Landscape | Customer Behavior | Regulatory Influence | Innovation Potential | 
|---|---|---|---|---|---|
| Drivers | High impact (e.g., tech adoption, rising demand) | Encourages new entrants and fosters expansion | Increases usage and enhances demand elasticity | Often aligns with progressive policy trends | Fuels R&D initiatives and product development | 
| Restraints | Slows growth (e.g., high costs, supply chain issues) | Raises entry barriers and may drive market consolidation | Deters consumption due to friction or low awareness | Introduces compliance hurdles and regulatory risks | Limits innovation appetite and risk tolerance | 
| Opportunities | Unlocks new segments or untapped geographies | Creates white space for innovation and M&A | Opens new use cases and shifts consumer preferences | Policy shifts may offer strategic advantages | Sparks disruptive innovation and strategic alliances | 
Drivers, Restraints and Opportunity Analysis
Drivers
- Increasing Healthcare Demand
- Advancements in Technology
- Growing Geriatric Population
- Rising Prevalence Rates
-  Blood Donation Awareness : Blood Donation Awareness is a pivotal factor influencing the Global Blood Collection Market. Increased awareness campaigns and educational programs have significantly contributed to changing societal attitudes toward blood donation. Through targeted initiatives and media outreach, organizations have successfully highlighted the critical need for blood donations to support medical treatments, surgeries, and emergencies. Public awareness about the lifesaving potential of blood donations has led to a growing number of voluntary donors, bolstering blood collection efforts globally. Technological advancements in communication platforms, such as social media, have played a crucial role in amplifying blood donation awareness. Organizations utilize these platforms to share real-time updates, success stories, and information about donation drives, effectively reaching wider audiences and encouraging participation. The use of digital tools, mobile apps, and online portals has streamlined the donor registration process, making it more accessible and convenient for individuals to pledge their support for blood donation initiatives. Partnerships between healthcare institutions, non-profit organizations, and government agencies have strengthened blood donation awareness campaigns. Collaborative efforts enable the pooling of resources, expertise, and outreach strategies, maximizing the impact of awareness programs. By fostering a culture of altruism and community engagement, blood donation awareness initiatives not only increase donor numbers but also promote a sense of social responsibility and solidarity in addressing healthcare challenges related to blood supply. 
Restraints
- Regulatory Compliance Challenges
- Limited Blood Donors
- Cost Constraints
- Blood Collection Safety
-  Cultural and Social Factors : Cultural and Social Factors poses significant challenges to the Global Blood Collection Market. Cultural beliefs, traditions, and taboos surrounding blood and donation practices vary widely across regions and communities. In some cultures, there may be deep-rooted misconceptions or fears related to blood donation, stemming from historical beliefs or religious teachings. These cultural barriers can create reluctance among potential donors, impacting blood collection efforts and supply levels. Social factors, including stigma and discrimination, also contribute to the restraint faced by the blood collection market. Individuals may avoid donating blood due to concerns about privacy, confidentiality, or societal judgment. Fear of needles, medical procedures, or perceived health risks can further deter people from participating in blood donation drives. Overcoming these cultural and social barriers requires tailored education campaigns, sensitivity to diverse beliefs, and community engagement strategies that address specific concerns and misconceptions related to blood donation. Efforts to mitigate the impact of cultural and social factors on blood donation include targeted outreach programs, culturally sensitive messaging, and collaboration with community leaders and influencers. By fostering open dialogues, dispelling myths, and addressing concerns transparently, organizations can create a more inclusive and welcoming environment for blood donors from diverse backgrounds. 
Opportunities
- Emerging Markets Expansion
- Technological Innovations Integration
- Collaboration with Healthcare Institutions
- Increased Blood Banking
-  Mobile Blood Drives : Mobile Blood Drives presents a dynamic avenue for expanding blood collection efforts and reaching underserved populations. Mobile blood drives involve setting up temporary donation centers in various locations such as workplaces, educational institutions, community centers, and public events. This approach enhances accessibility, convenience, and participation in blood donation, particularly among individuals who may face logistical barriers or time constraints. Mobile blood drives leverage technology, outreach strategies, and donor incentives to engage communities and encourage regular blood donations. They capitalize on the flexibility of scheduling, allowing organizations to target specific demographics, respond to emergencies, and adapt to changing demand patterns. By bringing donation services closer to donors' locations, mobile drives improve donor retention rates and create ongoing opportunities for individuals to contribute to the blood supply. Mobile blood drives support broader outreach efforts, enabling blood collection agencies to reach diverse populations, including rural areas, remote regions, and transient communities. Through partnerships with local businesses, government agencies, and community organizations, mobile drives can amplify their impact, raise awareness about blood donation, and cultivate a culture of civic engagement and public health responsibility. Embracing mobile blood drives as a strategic opportunity enhances blood collection efficiency, strengthens community bonds, and ensures a sustainable and robust blood supply chain. 
Blood Collection Market Competitive Landscape Analysis
Blood Collection Market is characterized by intense competition where leading players focus on growth, innovation, and collaboration to strengthen their positions. Companies frequently engage in merger and partnerships, driving market share consolidation of more than 40%. Strategic alliances and brand differentiation remain central to sustaining long-term presence in this evolving sector.
Market Structure and Concentration
The market reflects a moderate-to-high concentration, with top companies controlling over 55%. This structure encourages strategies aimed at diversification, technology-driven innovation, and regional expansion. Competitive intensity has led to improved service models and efficiency, while smaller firms adopt niche specialization to remain relevant amid dominant market leaders.
Brand and Channel Strategies
Key players emphasize robust brand visibility and optimized channel strategies to capture more than 60% of demand. Distribution relies heavily on partnerships, supplier networks, and direct healthcare channels. Companies invest in promotional campaigns and digital platforms, reinforcing customer trust while ensuring accessibility and consistent product availability across diverse medical settings.
Innovation Drivers and Technological Advancements
Over 50% of industry transformation is powered by technological advancements, particularly in automated devices and smart collection systems. Continuous innovation supports safety, efficiency, and diagnostic accuracy. Leaders prioritize R&D and collaboration with research institutes, driving competitive differentiation and reshaping product portfolios to address evolving clinical needs in healthcare environments.
Regional Momentum and Expansion
More than 45% of market growth is concentrated in emerging regions where infrastructure upgrades fuel expansion. Companies pursue regional strategies through distribution partnerships, acquisitions, and localized production. This momentum enhances availability, strengthens collaboration with healthcare institutions, and secures long-term demand across rapidly industrializing economies with rising medical awareness.
Future Outlook
The future landscape will be shaped by sustained innovation, digital integration, and collaborative strategies. More than 50% of upcoming growth is projected to stem from advanced automation and data-driven platforms. Companies aligning with technological advancements and regional expansion will establish stronger market positions, ensuring resilience and competitiveness in the long term.
Key players in Blood Collection Market include :
- Abbott Laboratories
- Becton, Dickinson and Company (BD)
- Cardinal Health
- Terumo Corporation
- Greiner Bio-One International GmbH
- Haemonetics Corporation
- Medtronic plc
- QIAGEN N.V.
- Nipro Corporation
- Fresenius SE & Co. KGaA
- Sarstedt AG & Co. KG
- FL Medical S.r.l.
- McKesson Corporation
- Streck, Inc.
- Siemens Healthineers
In this report, the profile of each market player provides following information:
- Market Share Analysis
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction - Research Objectives and Assumptions
- Research Methodology
- Abbreviations
 
- Market Definition & Study Scope
- Executive Summary - Market Snapshot, By Site
- Market Snapshot, By Application
- Market Snapshot, By Method
- Market Snapshot, By End Use
- Market Snapshot, By Region
 
- Blood Collection Market Dynamics - Drivers, Restraints and Opportunities - Drivers - Increasing Healthcare Demand
- Advancements in Technology
- Growing Geriatric Population
- Rising Prevalence Rates
- Blood Donation Awareness
 
- Restraints - Regulatory Compliance Challenges
- Limited Blood Donors
- Cost Constraints
- Blood Collection Safety
- Cultural and Social Factors
 
- Opportunities - Emerging Markets Expansion
- Technological Innovations Integration
- Collaboration with Healthcare Institutions
- Increased Blood Banking
- Mobile Blood Drives
 
 
- Drivers 
- PEST Analysis - Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
 
- Porter's Analysis - Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
 
 
- Drivers, Restraints and Opportunities 
- Market Segmentation - Blood Collection Market, By Site, 2021 - 2031 (USD Million) - Venous
- Capillary
 
- Blood Collection Market, By Application, 2021 - 2031 (USD Million) - Diagnostics
- Treatment
 
- Blood Collection Market, By Method, 2021 - 2031 (USD Million) - Manual Blood Collection
- Automated Blood Collection
 
- Blood Collection Market, By End Use, 2021 - 2031 (USD Million) - Hospitals
- Diagnostics Centers
- Blood Banks
- Emergency Departments
- Others
 
- Blood Collection Market, By Geography, 2021 - 2031 (USD Million) - North America - United States
- Canada
 
- Europe - Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
 
- Asia Pacific - Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
 
- Middle East & Africa - GCC
- Israel
- South Africa
- Rest of Middle East & Africa
 
- Latin America - Brazil
- Mexico
- Argentina
- Rest of Latin America
 
 
- North America 
 
- Blood Collection Market, By Site, 2021 - 2031 (USD Million) 
- Competitive Landscape - Company Profiles - Abbott Laboratories
- Becton, Dickinson and Company (BD)
- Cardinal Health
- Terumo Corporation
- Greiner Bio-One International GmbH
- Haemonetics Corporation
- Medtronic plc
- QIAGEN N.V.
- Nipro Corporation
- Fresenius SE & Co. KGaA
- Sarstedt AG & Co. KG
- FL Medical S.r.l.
- McKesson Corporation
- Streck, Inc.
- Siemens Healthineers
 
 
- Company Profiles 
- Analyst Views
- Future Outlook of the Market


 Download Sample
Download Sample Add to Cart
Add to Cart